Literature DB >> 27497891

Are Modic changes associated with intervertebral disc cytokine profiles?

Gregory D Schroeder1, Dessislava Z Markova2, John D Koerner3, Jeffery A Rihn3, Alan S Hilibrand3, Alexander R Vaccaro3, D Greg Anderson3, Christopher K Kepler3.   

Abstract

BACKGROUND CONTEXT: Degenerative changes including Modic changes (MCs) are commonly observed in patients with chronic low back pain. Although intervertebral disc (IVD) cytokine expression has been shown to be associated with low back pain, the cytokine profile for degenerative IVD with and without MC has not been compared.
PURPOSE: This study aimed to evaluate the potential association between IVD cytokine expression and MCs. STUDY
DESIGN: A laboratory study was carried out.
METHODS: The IVD tissue samples from 10 patients with type II MCs and10 patients without MCs who underwent an anterior lumbar interbody and fusion for significant low back pain were collected. The expression levels of 42 cytokines were determined using a RayBio Human Cytokine Antibody Array 3 (RayBiotech Inc, Norcross, GA, USA) and the results were verified with enzyme-linked immunosorbent assay (ELISA).
RESULTS: The cytokine array demonstrated a statistically significant increase in the expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) (p=.001) and epithelial-derived neutrophil-activating peptide 78 (ENA-78) (p=.04), and a trend toward an increase in interleukin-1β (IL-1β) (p=.12) and tumor necrosis factor-α (TNF-α) (p=.22) in IVDs associated with type II MCs. These results were validated with ELISA which demonstrated a 3.85-fold increase in the GM-CSF level between IVDs with type II MCs compared with those without MCs (p=.03). Similarly there was a significant increase in the level of both ENA-78 (3.68-fold, p=.02) and IL-1β (2.11-fold, p=.01) in IVDs with type II MCs. Lastly, there was a trend (p=.07) toward an increase in TNF-α in IVDs with type II MCs (4.4-fold).
CONCLUSION: Intervertebral discs with type II MCs demonstrate a significant increase in IL-1β, GM-CSF, and ENA-78, and there is a trend toward an increase in TNF-α. These results further strengthen the association between MCs and low back pain.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; Degenerative discs; Intervertebral disc; Low back pain; Lumbar spine; Modic changes

Mesh:

Substances:

Year:  2016        PMID: 27497891     DOI: 10.1016/j.spinee.2016.08.006

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  12 in total

1.  Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: a prospective randomized double-blind sham-controlled multi-center study.

Authors:  Jeffrey S Fischgrund; A Rhyne; J Franke; R Sasso; S Kitchel; H Bae; C Yeung; E Truumees; M Schaufele; P Yuan; P Vajkoczy; M DePalma; D G Anderson; L Thibodeau; B Meyer
Journal:  Eur Spine J       Date:  2018-02-08       Impact factor: 3.134

2.  Serum biomarkers for Modic changes in patients with chronic low back pain.

Authors:  Jaro Karppinen; Katri Koivisto; Jukka Ketola; Marianne Haapea; Markus Paananen; Karl-Heinz Herzig; Mauro Alini; Jeffrey Lotz; Stefan Dudli; Dino Samartzis; Juha Risteli; Marja-Leena Majuri; Harri Alenius; Eero Kyllönen; Jyri Järvinen; Jaakko Niinimäki; Sibylle Grad
Journal:  Eur Spine J       Date:  2021-01-09       Impact factor: 3.134

3.  ISSLS PRIZE IN BASIC SCIENCE 2017: Intervertebral disc/bone marrow cross-talk with Modic changes.

Authors:  Stefan Dudli; David C Sing; Serena S Hu; Sigurd H Berven; Shane Burch; Vedat Deviren; Ivan Cheng; Bobby K B Tay; Todd F Alamin; Ma Agnes Martinez Ith; Eric M Pietras; Jeffrey C Lotz
Journal:  Eur Spine J       Date:  2017-01-31       Impact factor: 3.134

Review 4.  Cervical disc degeneration: important considerations for the manual therapist.

Authors:  Brian T Swanson; Douglas Creighton
Journal:  J Man Manip Ther       Date:  2021-11-25

5.  Changes and significance of inflammatory cytokines in a rat model of cervical spondylosis.

Authors:  Jianjian Yin; Yongjing Huang; Gongming Gao; Luming Nong; Nanwei Xu; Dong Zhou
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

6.  Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain: 2-Year Results From a Prospective Randomized Double-Blind Sham-Controlled Multicenter Study.

Authors:  Jeffrey S Fischgrund; Alfred Rhyne; Jörg Franke; Rick Sasso; Scott Kitchel; Hyun Bae; Christopher Yeung; Eeric Truumees; Michael Schaufele; Philip Yuan; Peter Vajkoczy; Michael Depalma; David G Anderson; Lee Thibodeau; Bernhard Meyer
Journal:  Int J Spine Surg       Date:  2019-04-30

Review 7.  Intervertebral disc degeneration and regeneration: a motion segment perspective.

Authors:  B Ashinsky; H E Smith; R L Mauck; S E Gullbrand
Journal:  Eur Cell Mater       Date:  2021-03-24       Impact factor: 3.942

8.  Biomarkers in the Degenerative Human Intervertebral Disc Tissue and Blood.

Authors:  Yejia Zhang; Lutian Yao; Keith M Robinson; Timothy R Dillingham
Journal:  Am J Phys Med Rehabil       Date:  2021-12-27       Impact factor: 3.412

9.  Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain.

Authors:  Louise S C Nicol; Peter Thornton; Jon P Hatcher; Colin P Glover; Carl I Webster; Matthew Burrell; Kessia Hammett; Clare A Jones; Matthew A Sleeman; Andrew Billinton; Iain Chessell
Journal:  Pain       Date:  2018-03       Impact factor: 7.926

10.  Serum Biomarkers for Connective Tissue and Basement Membrane Remodeling are Associated with Vertebral Endplate Bone Marrow Lesions as Seen on MRI (Modic Changes).

Authors:  Stefan Dudli; Alexander Ballatori; Anne-Christine Bay-Jensen; Zachary L McCormick; Conor W O'Neill; Sibel Demir-Deviren; Roland Krug; Irina Heggli; Astrid Juengel; Jaro Karppinen; Florian Brunner; Mazda Farshad; Oliver Distler; Jeffrey C Lotz; Aaron J Fields
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.